M Korbelik
Overview
Explore the profile of M Korbelik including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
1741
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Separovic D, Bielawski J, Pierce J, Merchant S, Tarca A, Bhatti G, et al.
Int J Oncol
. 2010 Dec;
38(2):521-7.
PMID: 21152858
To improve anticancer therapeutic success of photodynamic therapy (PDT), combination treatments represent a viable strategy. Sphingolipid analogs combined with anticancer drugs can enhance tumor response. We have shown that LCL29,...
2.
Separovic D, Bielawski J, Pierce J, Merchant S, Tarca A, Ogretmen B, et al.
Br J Cancer
. 2009 Feb;
100(4):626-32.
PMID: 19223911
Photodynamic therapy (PDT) has been proven effective for treatment of several types of cancer. Photodynamic therapy alone, however, attains limited cures with some tumours and there is need for its...
3.
Korbelik M, Stott B, Sun J
Br J Cancer
. 2007 Nov;
97(10):1381-7.
PMID: 17971767
Recent investigations have established that tumour cells treated in vitro by photodynamic therapy (PDT) can be used for generating potent vaccines against cancers of the same origin. In the present...
4.
Korbelik M, Cooper P
Br J Cancer
. 2006 Dec;
96(1):67-72.
PMID: 17146472
Host response elicited by photodynamic therapy (PDT) of cancerous lesions is a critical contributor to the clinical outcome, and complement system has emerged as its important element. Amplification of complement...
5.
Korbelik M, Sun J, Zeng H
Br J Cancer
. 2003 Mar;
88(5):760-6.
PMID: 12618887
Prompted by the observation of ischaemia development during the treatment of tumours by photodynamic therapy (PDT) that is typically followed by a restoration of tumour blood flow and by the...
6.
Cecic I, Parkins C, Korbelik M
Photochem Photobiol
. 2001 Nov;
74(5):712-20.
PMID: 11723800
Photodynamic therapy (PDT) of solid tumors elicits a strong, acute inflammatory response characterized by a rapid and massive infiltration of activated neutrophils into the tumor. The present study investigated the...
7.
Bissonnette R, Zeng H, McLean D, Korbelik M, Lui H
Photochem Photobiol
. 2001 Sep;
74(2):339-45.
PMID: 11547574
Photodynamic therapy (PDT) with topical aminolevulinic acid (ALA) has been shown in previous studies to improve psoriasis. However, topical ALA-PDT may not be practical for the treatment of extensive disease....
8.
Korbelik M, Sun J
Int J Cancer
. 2001 Jun;
93(2):269-74.
PMID: 11410876
Adoptive immunotherapy mediated by human natural killer (NK) cell line genetically altered to produce interleukin-2 (NK92MI) was evaluated as adjuvant to photodynamic therapy (PDT) of subcutaneous tumors. The combined effect...
9.
Korbelik M, Sun J, Posakony J
Photochem Photobiol
. 2001 May;
73(4):403-9.
PMID: 11332036
Subcutaneous mouse EMT6 tumors were treated by individual or combined regimens of a single Bacillus Calmette-Guérin (BCG) vaccine administration and photodynamic therapy (PDT). Six clinically relevant photosensitizers characterized by different...
10.
Korbelik M, Parkins C, Shibuya H, Cecic I, Stratford M, Chaplin D
Br J Cancer
. 2000 Jun;
82(11):1835-43.
PMID: 10839299
The role of nitric oxide (NO) in the response to Photofrin-based photodynamic therapy (PDT) was investigated using mouse tumour models characterized by either relatively high or low endogenous NO production...